$16,128.30 speaking Payment -- Bayer Healthcare to Dr. Laura Hall

Ophthalmologist Laura Hall Earns Over $16,000 for Bayer Healthcare Speaking Engagement

This page provides a detailed analysis of a $16,128.30 speaking payment from Bayer Healthcare to Dr. Laura Hall. Data is from the CMS Open Payments (Sunshine Act) database.

Payment Details

FieldValue
Amount$16,128.30
Payment Typespeaking
Payment NatureCompensation for serving as faculty or as a speaker
Pharmaceutical CompanyBayer Healthcare
PhysicianDr. Laura Hall
NPI Number1170310799
Physician SpecialtyOphthalmology
LocationOrlando, FL
Date of Payment2025-07-22
Related Drug/DeviceEylea
Conflict AssessmentModerate -- Worth Noting

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

Bayer Healthcare made a $16.1K speaking payment to Laura Hall, a Ophthalmology specialist in Orlando, FL. The payment was associated with Eylea. Laura Hall received $16,128.30 from Bayer Healthcare for speaking engagements related to Eylea. The payment was for serving as faculty or a speaker, indicating an educational or promotional role. This payment occurred on July 22, 2025, and was made by Bayer Healthcare, a major pharmaceutical company.

Patient Guidance: What This Payment Means for You

If you are a patient, understand that your doctor may receive compensation for educating others about medications or devices like Eylea. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

Payments for speaking engagements in ophthalmology can vary widely, but this amount suggests a significant role as a faculty member or speaker for Bayer Healthcare regarding Eylea.

Regulatory Context: Sunshine Act Requirements

Physicians receiving compensation for speaking engagements must disclose these payments under the Sunshine Act, ensuring transparency in industry relationships.

Related Topics

This payment is related to the following healthcare transparency topics:

Understanding speaking Payments

Speaking and education payments compensate physicians for presenting at conferences, continuing medical education (CME) events, and promotional speaking engagements. These payments often cover honoraria, preparation time, and travel expenses. Speaking fees are among the highest-value payment categories and have attracted significant attention from researchers studying potential conflicts of interest.

Frequently Asked Questions About This Payment

What was this $16.1K payment for?

This was a speaking payment of $16.1K from Bayer Healthcare to Laura Hall, categorized as "Compensation for serving as faculty or as a speaker". It was associated with Eylea. The payment was reported under the Sunshine Act (CMS Open Payments).

Does Laura Hall accept pharmaceutical money?

Yes, Laura Hall received this $16.1K payment from Bayer Healthcare. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Laura Hall's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this speaking payment?

A speaking payment of $16.1K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Ophthalmology?

To compare this payment against Ophthalmology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Ophthalmology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Laura Hall's relationship with Bayer Healthcare?

The payment amount is substantial, suggesting significant involvement in speaking activities. This $16.1K speaking payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Ophthalmology?

The specific drug mentioned, Eylea, is a key product for ophthalmology treatments.

What should patients do after learning about this payment?

If you are a patient, understand that your doctor may receive compensation for educating others about medications or devices like Eylea.

What else should I know about this speaking payment?

The payment was made by Bayer Healthcare, a company with a broad portfolio in pharmaceuticals.

Related Reports

Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.